NCT01986218View on ClinicalTrials.gov

Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Various Advanced Cancer
Interventions
DRUG

BMS-986115

Trial Locations (4)

3050

Local Institution, Parkville

90033

Usc/Norris Comprehensive Cancer Center, Los Angeles

V5Z 4E6

Local Institution, Vancouver

M5G 2M9

Local Institution, Toronto

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01986218 - Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter